Prilenia–Leucadia: investor conference, 202006 supply service Prilenia presents at Jefferies 2020 Virtual Healthcare Conference

	Period	2020-06-03
	Partner, 1st	Prilenia Therapeutics B.V.
	Group	Prilenia (Group)
	Partner, 2nd	Jefferies LLC
	Group	Leucadia (Group)
	Product	Jefferies 2020 Virtual Healthcare Conference
	Product 2	pridopidine
	Person	Hayden, Michael R. (Prilenia Therapeutics 202006– CEO former President Global RnD + CSO at Teva)
	Source	Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference".

Record changed: 2020-06-06

More documents for Prilenia (Group)

[1] Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya....
[2] Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]